Catalyst Capital Advisors LLC Merck & Co., Inc. Transaction History

Catalyst Capital Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$123.8 - $132.96 $24,760 - $26,592	-200 Reduced 0.54%	36,800 $4.56 Million
Q1 2024 Apr 24, 2024	SELL	$113.24 - $131.95 $79,268 - $92,364	-700 Reduced 1.86%	37,000 $4.88 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $300,540 - $327,060	-3,000 Reduced 7.37%	37,700 $4.11 Million
Q3 2023 Nov 09, 2023	SELL	$102.95 - $114.33 $159,572 - $177,211	-1,550 Reduced 3.67%	40,700 $4.19 Million
Q2 2023 Aug 08, 2023	SELL	$108.61 - $118.38 $249,803 - $272,274	-2,300 Reduced 5.16%	42,250 $4.88 Million
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $313,967 - $350,323	-3,050 Reduced 6.41%	44,550 $4.74 Million
Q4 2022 Feb 07, 2023	BUY	$87.44 - $112.11 $4.16 Million - $5.34 Million	47,600 New	47,600 $5.28 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Catalyst Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Catalyst Capital Advisors LLC with notifications on news.